Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso

Table 1 Estimated sample size for baseline IPTp-SP and SMC HHS

Country	Outcomes		Estimated sample size	Estimated number of households to be visited^a
Mali	Estimated IPTp3 +	28%, up to 40%	775	3,875
Mali	Estimated SMC coverage 4 doses	54%	802	802
Burkina Faso	Estimated IPTp3 +	58%	786	3,930
Burkina Faso	Estimated SMC coverage 4 doses	90%	290	290

^aIt is assumed that at least one woman in every five households will meet the inclusion criteria and there will be a non-response rate of 5%. Sources: MIS 2018, for Burkina Faso [18]; ACCESS SMC partnership [23]; Diawara et al. 2017 [24] and Kayentao et al. 2022, unpublished data, for Mali

ISSN: 1471-2458